KRAS and prostate carcinoma: Notably, when subjected to hallmark gene sets and KEGG pathway analysis using Metascape25, these shared genes demonstrated significant enrichment within oncogenic pathways, such as epithelial-mesenchymal transition, KRAS, IL6/JAK/STAT3, and the mTORC1 pathways (Fig. 2b), suggesting that ELAVL3 may function as a critical regulator in the progression of prostate cancer.